# KEPIVANCE

NDC: 66658-113
Generic name: palifermin
Labeler / Manufacturer: Swedish Orphan Biovitrum AB (publ)
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230804

FDA application: BLA125103

## Active ingredients

- PALIFERMIN: 5.16 mg/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66658-113"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66658-113
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=426f6e64-2c20-4a61-6d65-7320426f6e64